{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:58:55Z","timestamp":1790474335152,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ajog.2013.01.017","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T12:51:22Z","timestamp":1358427082000},"page":"310.e1-310.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Evidence of an imbalance of angiogenic\/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death"],"prefix":"10.1016","volume":"208","author":[{"given":"Amy E.","family":"Whitten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Korzeniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi L.","family":"Tarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyse G.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lami","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia S.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinnakorn","family":"Chaiworapongsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2013.01.017_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10024001-0195-y","article-title":"Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence","volume":"5","author":"Katzman","year":"2002","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.ajog.2013.01.017_bib2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0002-9378(90)91100-Q","article-title":"The association of maternal floor infarction of the placenta with adverse perinatal outcome","volume":"163","author":"Andres","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib3","series-title":"The pathology of the human placenta","author":"Benirschke","year":"1974"},{"key":"10.1016\/j.ajog.2013.01.017_bib4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0046-8177(85)80254-9","article-title":"Maternal floor infarction","volume":"16","author":"Naeye","year":"1985","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajog.2013.01.017_bib5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1471-0528.2003.00119.x","article-title":"Massive perivillous fibrinoid causing recurrent placental failure","volume":"110","author":"Bane","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2013.01.017_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/15513819609169291","article-title":"Maternal floor infarction in autoimmune disease: two cases","volume":"16","author":"Bendon","year":"1996","journal-title":"Pediatr Pathol Lab Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib7","first-page":"750","article-title":"Maternal floor infarction of the placenta: prenatal diagnosis and clinical significance","volume":"83","author":"Mandsager","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib8","first-page":"1270","article-title":"Maternal floor infarction: an unusual cause of intrauterine growth retardation","volume":"142","author":"Nickel","year":"1988","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.ajog.2013.01.017_bib9","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0046-8177(03)00288-0","article-title":"Discordancy for maternal floor infarction in dizygotic twin placentas","volume":"34","author":"Redline","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajog.2013.01.017_bib10","first-page":"258","article-title":"Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients","volume":"101","author":"Sebire","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1471-0528.2002.00077.x","article-title":"Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome","volume":"109","author":"Sebire","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2013.01.017_bib12","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0002-9378(11)91716-5","article-title":"Maternal floor infarction: relationship to X cells, major basic protein, and adverse perinatal outcome","volume":"167","author":"Vernof","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0002-9378(83)91130-4","article-title":"Recurrent maternal floor infarction: a preventable cause of fetal death","volume":"147","author":"Clewell","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib14","first-page":"1","article-title":"Pathology of the placenta","volume":"7","author":"Fox","year":"1978","journal-title":"Major Probl Pathol"},{"key":"10.1016\/j.ajog.2013.01.017_bib15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2350\/07-06-0306.1","article-title":"Recurrent placental massive perivillous fibrin deposition associated with polymyositis: a case report and review of the literature","volume":"11","author":"Al-Adnani","year":"2008","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.ajog.2013.01.017_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/art.21710","article-title":"Pregnancy-related polymyositis and massive perivillous fibrin deposition in the placenta: are they pathogenetically related?","volume":"55","author":"Hung","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajog.2013.01.017_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jez.1402510210","article-title":"Vasculogenesis and angiogenesis: two distinct morphogenetic mechanisms establish embryonic vascular pattern","volume":"251","author":"Poole","year":"1989","journal-title":"J Exp Zool"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2013.01.017_bib18","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0301-2115(03)00168-4","article-title":"Angiogenesis and vasculogenesis in pregnancy","volume":"110","author":"Zygmunt","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2013.01.017_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","article-title":"Mechanisms of angiogenesis","volume":"386","author":"Risau","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2013.01.017_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/dbio.1999.9534","article-title":"Endoglin, an ancillary TGF beta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development","volume":"217","author":"Arthur","year":"2000","journal-title":"Dev Biol"},{"key":"10.1016\/j.ajog.2013.01.017_bib21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI8088","article-title":"A murine model of hereditary hemorrhagic telangiectasia","volume":"104","author":"Bourdeau","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajog.2013.01.017_bib22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/380435a0","article-title":"Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele","volume":"380","author":"Carmeliet","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2013.01.017_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/380439a0","article-title":"Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene","volume":"380","author":"Ferrara","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2013.01.017_bib24","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.284.5419.1534","article-title":"Defective angiogenesis in mice lacking endoglin","volume":"284","author":"Li","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ajog.2013.01.017_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5483\/BMBRep.2008.41.4.278","article-title":"Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis","volume":"41","author":"Shibuya","year":"2008","journal-title":"BMB Rep"},{"key":"10.1016\/j.ajog.2013.01.017_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050500202493","article-title":"Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin","volume":"18","author":"Bujold","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib27","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ajog.2004.03.043","article-title":"Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia","volume":"190","author":"Chaiworapongsa","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/14767050701831397","article-title":"Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age","volume":"21","author":"Chaiworapongsa","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia","volume":"17","author":"Chaiworapongsa","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14767050802034545","article-title":"The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age","volume":"21","author":"Erez","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib31","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/jc.2002-021942","article-title":"Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia","volume":"88","author":"Koga","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2013.01.017_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0897.1997.tb00519.x","article-title":"Vascular endothelial growth factor is increased in patients with preeclampsia","volume":"38","author":"Kupferminc","year":"1997","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2013.01.017_bib33","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib34","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1471-0528.1997.tb11050.x","article-title":"Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia","volume":"104","author":"Lyall","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajog.2013.01.017_bib37","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.ajog.2004.03.004","article-title":"Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop","volume":"191","author":"McKeeman","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib38","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ajog.2005.06.033","article-title":"An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia","volume":"193","author":"Park","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib39","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1471-0528.1999.tb08107.x","article-title":"Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia","volume":"106","author":"Reuvekamp","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ajog.2005.12.049","article-title":"Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia","volume":"195","author":"Robinson","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","volume":"21","author":"Romero","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib42","doi-asserted-by":"crossref","first-page":"176.e1","DOI":"10.1016\/j.ajog.2007.03.036","article-title":"Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia","volume":"197","author":"Staff","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib43","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.HYP.0000258404.21552.a3","article-title":"Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion","volume":"49","author":"Stepan","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2013.01.017_bib44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1067\/mob.2003.111","article-title":"Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies","volume":"188","author":"Taylor","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib45","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1067\/mob.2001.113129","article-title":"Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia","volume":"184","author":"Tidwell","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib46","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0002-9378(98)70021-3","article-title":"Preeclampsia is associated with reduced serum levels of placenta growth factor","volume":"179","author":"Torry","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib47","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1210\/jc.2003-030528","article-title":"Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences","volume":"88","author":"Tsatsaris","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2013.01.017_bib48","doi-asserted-by":"crossref","first-page":"239.e1","DOI":"10.1016\/j.ajog.2006.10.909","article-title":"Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia","volume":"196","author":"Vatten","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib49","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib50","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/01.AOG.0000264552.85436.a1","article-title":"Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia","volume":"109","author":"Wikstrom","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib51","doi-asserted-by":"crossref","unstructured":"Benton SJ, Hu Y, Xie F, et al. Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays. Am J Obstet Gynecol;205:469.e1-8.","DOI":"10.1016\/j.ajog.2011.06.058"},{"key":"10.1016\/j.ajog.2013.01.017_bib52","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1067\/mob.2001.108342","article-title":"Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance","volume":"184","author":"Bosio","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/uog.7491","article-title":"Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations","volume":"35","author":"Chaiworapongsa","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib54","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3109\/14767058.2011.589932","article-title":"Maternal plasma concentrations of angiogenic\/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia","volume":"24","author":"Chaiworapongsa","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib55","doi-asserted-by":"crossref","first-page":"550.e1","DOI":"10.1016\/j.ajog.2010.04.002","article-title":"A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia","volume":"202","author":"Chaiworapongsa","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib56","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajog.2006.01.014","article-title":"Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction","volume":"195","author":"Crispi","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib57","doi-asserted-by":"crossref","first-page":"123717","DOI":"10.1155\/2011\/123717","article-title":"Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia","volume":"2011","author":"Furuya","year":"2011","journal-title":"J Pregnancy"},{"key":"10.1016\/j.ajog.2013.01.017_bib58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00404-011-1960-4","article-title":"Serum PLGF as a potential biomarker for predicting the onset of preeclampsia","volume":"285","author":"Ghosh","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2013.01.017_bib59","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajog.2005.10.192","article-title":"Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women","volume":"194","author":"Levine","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib60","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ajog.2005.08.034","article-title":"Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis","volume":"194","author":"Masuyama","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib61","doi-asserted-by":"crossref","first-page":"244.e1","DOI":"10.1016\/j.ajog.2007.06.030","article-title":"Angiogenic factors for the prediction of preeclampsia in high-risk women","volume":"197","author":"Moore Simas","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib62","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.111.181735","article-title":"Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy","volume":"59","author":"Perni","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2013.01.017_bib63","doi-asserted-by":"crossref","first-page":"174.e1","DOI":"10.1016\/j.ajog.2007.03.058","article-title":"Soluble endoglin as a second-trimester marker for preeclampsia","volume":"197","author":"Robinson","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib64","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/14767058.2011.591461","article-title":"Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion","volume":"25","author":"Soto","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib65","doi-asserted-by":"crossref","unstructured":"Srinivas SK, Morrison AC, Andrela CM, Elovitz MA. Allelic variations in angiogenic pathway genes are associated with preeclampsia. Am J Obstet Gynecol;202:445.e1-11.","DOI":"10.1016\/j.ajog.2010.01.040"},{"key":"10.1016\/j.ajog.2013.01.017_bib66","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.trsl.2012.01.005","article-title":"Pathogenesis of pre-eclampsia: marinobufagenin and angiogenic imbalance as biomarkers of the syndrome","volume":"160","author":"Uddin","year":"2012","journal-title":"Transl Res"},{"key":"10.1016\/j.ajog.2013.01.017_bib67","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2007.05.022","article-title":"Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia","volume":"197","author":"Unal","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib68","doi-asserted-by":"crossref","first-page":"161.e1","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib69","doi-asserted-by":"crossref","unstructured":"Verlohren S, Herraiz I, Lapaire O, et al. The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol;206:58.e1-8.","DOI":"10.1016\/j.ajog.2011.07.037"},{"key":"10.1016\/j.ajog.2013.01.017_bib70","doi-asserted-by":"crossref","first-page":"358.e10","DOI":"10.1016\/j.ajog.2012.01.009","article-title":"Haptoglobin phenotype, angiogenic factors, and preeclampsia risk","volume":"206","author":"Weissgerber","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14767050701832833","article-title":"The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation","volume":"21","author":"Chaiworapongsa","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib72","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/AOG.0b013e318256187f","article-title":"Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes","volume":"119","author":"Coolman","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib73","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/14767050802046069","article-title":"Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2","volume":"21","author":"Gotsch","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib74","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.placenta.2008.03.006","article-title":"Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia","volume":"29","author":"Jeyabalan","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2013.01.017_bib75","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1477-7827-9-107","article-title":"Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction","volume":"9","author":"Nishizawa","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ajog.2013.01.017_bib76","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/uog.3930","article-title":"Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction","volume":"29","author":"Schlembach","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib77","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/CS20060161","article-title":"Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction","volume":"112","author":"Wallner","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ajog.2013.01.017_bib78","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3109\/14767050902994838","article-title":"A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic\/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study","volume":"22","author":"Chaiworapongsa","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib79","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3109\/14767050903440471","article-title":"Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes","volume":"23","author":"Savasan","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib80","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.AOG.0000265804.09161.0d","article-title":"Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth","volume":"109","author":"Smith","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib81","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3109\/14767050903443467","article-title":"Unexplained fetal death is associated with increased concentrations of anti-angiogenic factors in amniotic fluid","volume":"23","author":"Chaiworapongsa","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib82","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/14767050701413022","article-title":"Unexplained fetal death: another anti-angiogenic state","volume":"20","author":"Espinoza","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib83","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3109\/14767051003681121","article-title":"An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study","volume":"23","author":"Romero","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib84","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/10641955.2011.638959","article-title":"Placental origins of angiogenic dysfunction in mirror syndrome","volume":"31","author":"Bixel","year":"2012","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2013.01.017_bib85","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/14767050600922677","article-title":"A role of the anti-angiogenic factor sVEGFR-1 in the \u201cmirror syndrome\u201d (Ballantyne's syndrome)","volume":"19","author":"Espinoza","year":"2006","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib86","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/uog.10136","article-title":"Angiogenic and anti-angiogenic factors before and after resolution of maternal mirror syndrome","volume":"40","author":"Llurba","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib87","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.AOG.0000248538.03280.cf","article-title":"Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors","volume":"109","author":"Rana","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib88","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/01.AOG.0000263776.46071.d1","article-title":"Cytomegalovirus-induced mirror syndrome associated with elevated levels of angiogenic factors","volume":"109","author":"Stepan","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib89","doi-asserted-by":"crossref","first-page":"382.e1","DOI":"10.1016\/j.ajog.2008.02.016","article-title":"Twin-to-twin transfusion syndrome: an antiangiogenic state?","volume":"198","author":"Kusanovic","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib90","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/uog.7515","article-title":"Maternal plasma and amniotic fluid angiogenic factors and their receptors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome","volume":"35","author":"Fox","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib91","doi-asserted-by":"crossref","first-page":"184.e1","DOI":"10.1016\/j.ajog.2009.09.005","article-title":"Angiogenic dysfunction in molar pregnancy","volume":"202","author":"Kanter","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.017_bib92","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.fertnstert.2009.02.015","article-title":"Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole","volume":"94","author":"Koga","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2013.01.017_bib93","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib94","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1022381506823","article-title":"1994-1996 US singleton birth weight percentiles for gestational age by race, Hispanic origin, and gender","volume":"3","author":"Alexander","year":"1999","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.ajog.2013.01.017_bib95","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0","article-title":"Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets","volume":"19","author":"Steyerberg","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib96","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/sj.jp.7210685","article-title":"Maternal floor infarction of the placenta: association with central nervous system injury and adverse neurodevelopmental outcome","volume":"22","author":"Adams-Chapman","year":"2002","journal-title":"J Perinatol"},{"key":"10.1016\/j.ajog.2013.01.017_bib97","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1542\/peds.109.4.650","article-title":"Placental features in preterm infants with periventricular leukomalacia","volume":"109","author":"Kumazaki","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2013.01.017_bib98","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2006-931805","article-title":"Intravenous immunoglobulin in antiphospholipid syndrome and maternal floor infarction when standard treatment fails: a case report","volume":"23","author":"Chang","year":"2006","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2013.01.017_bib99","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-2007-999778","article-title":"Maternal floor infarction of the placenta associated with elevated second trimester serum alpha-fetoprotein","volume":"4","author":"Katz","year":"1987","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2013.01.017_bib100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2002-33085","article-title":"Activated protein C resistance associated with maternal floor infarction treated with low-molecular-weight heparin","volume":"19","author":"Katz","year":"2002","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2013.01.017_bib101","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/mgme.2000.3135","article-title":"Placental floor infarction complicating the pregnancy of a fetus with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency","volume":"72","author":"Matern","year":"2001","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ajog.2013.01.017_bib102","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000147602","article-title":"Immunohistochemistry of two different types of placental fibrinoid","volume":"150","author":"Frank","year":"1994","journal-title":"Acta Anat (Basel)"},{"key":"10.1016\/j.ajog.2013.01.017_bib103","first-page":"855","article-title":"Trophoblast interaction with fibrin matrix","volume":"136","author":"Nelson","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2013.01.017_bib104","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0143-4004(77)90017-0","article-title":"Ontogenetic and phylogenetic evaluation of the presence of fibrin-type fibrinoid in the villous haemochorial placenta","volume":"18","author":"Nelson","year":"1997","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2013.01.017_bib105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jcp.29.Suppl_10.70","article-title":"Fibrin deposition in pregnancy","volume":"10","author":"Stalker","year":"1976","journal-title":"J Clin Pathol Suppl (Royal College of Pathologists)"},{"key":"10.1016\/j.ajog.2013.01.017_bib106","first-page":"253","article-title":"Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia","volume":"74","author":"Kanfer","year":"1996","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajog.2013.01.017_bib107","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00404-007-0452-z","article-title":"Placental morphometrical and histopathology changes in the different clinical presentations of hypertensive syndromes in pregnancy","volume":"277","author":"Correa","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2013.01.017_bib108","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.placenta.2010.02.016","article-title":"Variation in composition of the intervillous space lining in term placentas of mothers with pre-eclampsia","volume":"31","author":"Hottor","year":"2010","journal-title":"Placenta"},{"issue":"Spec No","key":"10.1016\/j.ajog.2013.01.017_bib109","first-page":"489","article-title":"Maternal vascular lesions in pre-eclampsia and intrauterine growth retardation: light microscopy and immunofluorescence","volume":"4","author":"Hustin","year":"1983","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2013.01.017_bib110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1084\/jem.118.3.467","article-title":"The pathogenic role of fibrin deposition in the glomerular lesions of toxemia of pregnancy","volume":"118","author":"Vassalli","year":"1963","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajog.2013.01.017_bib111","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.106.660134","article-title":"Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1","volume":"115","author":"Cudmore","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2013.01.017_bib112","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jri.2009.03.003","article-title":"Pravastatin prevents miscarriages in antiphospholipid antibody-treated mice","volume":"82","author":"Girardi","year":"2009","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ajog.2013.01.017_bib113","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1182\/blood-2008-12-194258","article-title":"Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury","volume":"113","author":"Redecha","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2013.01.017_bib114","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1073\/pnas.1011293108","article-title":"Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model","volume":"108","author":"Kumasawa","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajog.2013.01.017_bib115","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/HYPERTENSIONAHA.109.141937","article-title":"Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension","volume":"55","author":"Gilbert","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2013.01.017_bib116","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/HYPERTENSIONAHA.107.092098","article-title":"Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia","volume":"50","author":"Li","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2013.01.017_bib117","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1161\/HYPERTENSIONAHA.110.160242","article-title":"Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH\/5 mice","volume":"57","author":"Woods","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2013.01.017_bib118","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","article-title":"Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"124","author":"Thadhani","year":"2011","journal-title":"Circulation"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937813000537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937813000537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:51:44Z","timestamp":1757587904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937813000537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":118,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0002937813000537"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2013.01.017","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence of an imbalance of angiogenic\/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2013.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}